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Abstract
Background: NGF exerts a variety of actions including promotion of neuronal differentiation and
survival. The PC12 rat pheochromocytoma cell line has proved valuable for studying how NGF
works and has revealed that the NGF mechanism includes regulation of gene expression.
Accordingly, we used SAGE (Serial Analysis of Gene Expression) to compare levels of specific
transcripts in PC12 cells before and after long-term NGF exposure. Of the approximately 22,000
transcripts detected and quantified, 4% are NGF-regulated by 6-fold or more. Here, we used
database information to identify transcripts in our SAGE libraries that encode ribosomal proteins
and have compared the effect of NGF on their relative levels of expression.
Results: Among the transcripts detected in our SAGE analysis, 74 were identified as encoding
ribosomal proteins. Ribosomal protein transcripts were among the most abundantly expressed
and, for naive and NGF-treated PC12 cells, represented 5.2% and 3.5%, respectively, of total
transcripts analyzed. Surprisingly, nearly half of ribosomal protein transcripts underwent
statistically significant NGF-promoted alterations in relative abundance, with changes of up to 5-
fold. Of the changes, approximately 2/3 represented decreases. A time course revealed that the
relative abundance of transcripts encoding RPL9 increases within 1 hr of NGF treatment and is
maximally elevated by 8 hr.
Conclusions: These data establish that NGF selectively changes expression of ribosomal protein
transcripts. These findings raise potential roles for regulation of ribosomal protein transcripts in
NGF-promoted withdrawal from the cell cycle and neuronal differentiation and indicate that
regulation of individual ribosomal protein transcripts is cell- and stimulus-specific.
Background
Nerve growth factor (NGF), a prototypical neurotrophic
factor and a member of the neurotrophin family, pro-
motes a wide range of responses in its target cells. These
range from neuronal differentiation, maintenance of sur-
vival, and regulation of metabolic activities [for review see
[1–3]. Many of these actions include and require tran-
scriptional regulation [4,5]. However, the greater part of
the changes in gene expression that underlie the NGF re-
sponse remain to be elucidated. The PC12 line of rat phe-
ochromocytoma cells [6] has proved to be a particularly
favorable system for detecting NGF-responsive changes in
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gene expression [7–11]. These cells resemble sympathico-
pheochromo-blasts and upon exposure to NGF cease pro-
liferation and acquire, in a transcription dependent mech-
anism, many of the properties of post-mitotic sympathetic
neurons including neurite outgrowth and electrical excit-
ability. The robust nature of the response of PC12 cells to
NGF coupled with their capacity to be examined both be-
fore and at various times after exposure to the factor has
greatly facilitated study of the NGF mechanism of action,
including gene regulation [12].
To obtain a comprehensive and quantitative over-view of
NGF-promoted gene regulation, we [11] have used SAGE
(Serial Analysis of Gene Expression). In this technique
[13–15] cellular transcripts are converted to SAGE "tags"
which are sequenced, quantified and, in many cases,
matched with known genes. By comparing SAGE profiles
for cells in different states (as for example before and after
exposure to NGF), it is thus possible to obtain a compre-
hensive view of gene expression and regulation. Moreo-
ver, if a sufficient number of SAGE tags are analyzed,
changes in expression levels of individual transcripts can
be associated with a high level of statistical significance
[13].
Initial analysis of approximately 157,000 SAGE tags from
PC12 cells cultured without or with NGF for 9 days re-
vealed nearly 800 transcripts (of a total of at least 21,000)
that are regulated by ± 6-fold or greater in response to
NGF [11]. Of these, approximately 150 were assignable to
named genes of known functions that regulate cellular be-
haviors ranging from actin and microtubule cytoskeleton
assembly/disassembly, gene transcription, RNA process-
ing, neurotransmission, and energetics. A variety of crite-
ria supported the reliability of the quantitative findings
revealed by our SAGE analysis [11].
In the present study, we have extended our SAGE profiling
of naïve and long-term NGF-treated PC12 cells to over
163,000 tags representing over 22,000 unique transcripts.
Analysis of these reveals the presence of transcripts encod-
ing 74 different ribosomal proteins (RPs). Surprisingly,
we find that long-term NGF exposure leads to statistically
significant changes in relative abundance of at least half of
these transcripts by factors of up to nearly 5-fold. In addi-
tion, a time course for one of the RP transcripts (encoding
RP L9) reveals that its relative abundance begins to change
within 1 hr and is maximally regulated by 8 hr of NGF ex-
posure.
Results
SAGE libraries
SAGE libraries were generated and analyzed as previously
described [11] from matched sets of PC12 cells before and
after 9 days of exposure to NGF. The present analysis is
based on 76,280 15-mer tags from NGF-untreated PC12
cells and 87,004 tags from NGF-treated cells (after exclu-
sion of duplicate ditags, mitochondrial transcripts and re-
petitive elements). Consideration of tags observed twice
or more between the two libraries indicated the presence
of approximately 22,000 unique transcripts. Of these, ap-
proximately 10% were regulated by more than 3-fold in
response to NGF and approximately 4% by 6-fold or
more.
Detection and quantification of transcripts encoding ribos-
omal proteins
Transcripts represented by SAGE tags were identified by
direct matches of tags with the appropriate sequences of
known rat genes (present in GenBank) or through match-
es of tags with appropriate sequences of rat ESTs (present
in NCBI Unigene) that were in turn found to overlap with
known rat genes. Positive identification required that the
transcript or EST have a poly adenylation signal and poly
A tail, and that the tag followed the most 3' CATG of the
transcript. In this way 74 tags were unambiguously assign-
able to known rat transcripts encoding proteins described
as ribosomal components. Available sequences encoding
rat ribosomal proteins L15 and S8 do not contain a CATG
sequence and hence SAGE tags for these could not be
identified. In addition, rat sequence data for transcripts
encoding RPs L2, L25, L33 and S1 are not presently avail-
able in GenBank or Unigene.
Table 1 lists the tags in our libraries corresponding to tran-
scripts for ribosomal proteins along with their relative
abundances. Considering that the eukaryotic ribosome
contains approximately 82 proteins, our analysis includes
transcripts encoding a major proportion of the known ri-
bosomal proteins.
Relative expression of transcripts for ribosomal proteins
Among the information provided by analysis of SAGE
data is the relative abundances of transcripts. The data giv-
en in Table 1 and Figure 1 show the relative abundances
of transcripts for PC12 cell ribosomal proteins with re-
spect to one another as well as with respect to the total cell
complement of transcripts. As noted above, our analysis
has detected at least 22,000 unique transcripts in PC12
cells. The 74 ribosomal protein transcripts identified here
thus account for no more than 0.33% of this total. By con-
trast, for NGF-untreated and -treated PC12 cells, tags cor-
responding to the 74 identified RP transcripts represent
5.2% and 3.5%, respectively, of total tags analyzed. As an-
ticipated, this clearly places transcripts for ribosomal pro-
teins as a whole in the high abundance category.
The most abundantly expressed ribosomal transcripts in
NGF-untreated PC12 cells included those encoding ribos-
omal proteins S15, S24 and L41. These each accounted forBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/3
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Table 1: The effect of NGF (9 days treatment) on expression levels of transcripts for various ribosomal proteins in PC12 cell cultures
TAG RP ACC# #TAGS- #TAGS+ FOLD CHANGE +NGF P value
GGACCGCTCAA L3 X62166 44 27 ↓  1.6 0.06
TTGAAGCTGAA L4/L1 X82180 49 39 ↓  1.3 0.2
CTGCTATCCGA L5 X06148 40 28 ↓  1.4 0.15
TACCCTCACAA L6 X87107 16 24 ↑  l.5 0.05
AGATCTATACA L7 Ml 7422 8 7 ↓  1.1 0.5
CACCACTGTTG L7A X15013 63 47 ↓  1.3 0.2
AATCCTGTGGA L8 P25120 119 58 ↓  2.1 0.0002
ATCAAGGGTGT L9 X51706 7 19 ↑  2.7 0.01
TTCAATAATAA L10 X87106 24 17 ↓  1.4 0.2
GGCAAGCCCCA L10A X93352 26 30 ↑  1.2 0.2
CGCTGGTTCCA L11 X62146 18 23 ↑  .3 0.1
ACATCATAGAT L12 R7RT12 59 15 ↓  3.9 < 0.0001
GCCCGAGCCAA L13 X78327 48 57 ↑  .2 0.1
AGGTCGGGTGG L13A X68282 87 118 ↑  1.3 0.002
AGGAGGCTACA L14 X94242 31 51 ↑  1.6 0.003
GCACGGGAATA L17 X58389 8 26 ↑  3.2 0.0007
GGTGTTGACAT L18 M20156 47 12 ↓  3.9 < 0.0001
AAGGTGGAAGA L18A JC4231 56 33 ↓  1.7 0.03
GATCAGTCATT L19 X82202 65 63 ↓  1.0 0.3
GCCTAATGTAT L21 M27905 43 32 1.3 0.2
TTTTGTATTAA L22 X78444 5 4 1.3 0.7
GTGATGGCCAC L23 X58200 72 63 ↓  1.1 0.4
AAGGTCGAGCT L24 X78443 95 28 ↓  3.4 < 0.0001
CCCAGTTTTCA L26 X14671 31 19 ↓  1.6 0.1
CCCACAAGGTA L27 X07424 16 30 ↑  1.9 0.007
ATCCGAAAAAA L28 X52619 42 10 ↓  4.2 0.0001
GCCAAGGGTCG L29 X68283 97 40 ↓  2.4 < 0.0001
CCAGAACAGAC L30 X52619 36 9 ↓  4.0 0.0002
AAGGAGATGGG L31 X04809 64 111 ↑  1.7 < 0.0001
CTGCCTAGCGG L32 X06483 26 20 ↓  1.3 0.2
TGCGCCAAGTG L34 X14401 27 30 ↑  1.1 0.2
AAGAGAAGCTG L35 X51705 115 70 ↓  1.6 0.009
GTTCGTGCCAA L35A X03475 33 16 ↓  2.1 0.04
CGGAAGGCGGC L36 X68284 38 77 ↑  2.0 < 0.0001
GATTCCGTGAA L37 X66369 58 79 ↑  1.4 0.01
AAAACAGTGGC L37A X14069 55 90 ↑  1.6 0.0003
TGACTATTAAA L38 X57007 25 21 ↓  1.2 0.5
TCTTCTCACAA L39 X82551 15 27 ↑  1.8 0.03
CAGATCTTCGT L40 X82636 89 32 ↓  2.8 < 0.0001
AGAGCGAAGTG L41 X82550 185 80 ↓  2.3 < 0.0001
CAAGGTGACAG S2 U92700 52 47 ↓  1.1 0.4
CCTCAGCCAGT S3 X51536 21 35 ↑  1.7 0.03
GTGAAGGCGGT S3A X75161 46 43 ↓  1.1 0.4
ATGAAATCAAA S4 X14210 44 20 ↓  2.2 0.01
CCTTTGAGATC S5 X58465 72 34 ↓  2.1 0.004
GCAGAGTGCGC S6 NM_017160 63 27 ↓  2.3 0.0006
TTCAGCTCGAG S7 X53377 41 31 ↓  1.3 0.3
CCCGTGTGCTC S9 X66370 54 32 ↓  1.7 0.06
CAGTCTCTCAA S10 X13549 57 36 ↓  1.6 0.02
TCTGTGCACCT S11 K03250 23 18 ↓  1.3 0.4
TATGTCAAGCT S12 M18547 92 52 ↓  1.8 0.006
GTGTGGCACAG S13 X53378 65 65 1.0 0.2
TTGGCTGCCCA S14 X15040 99 50 ↓  2.0 0.0008
GTGGGTGTGTA S15 NM_017151 254 60 ↓  4.2 < 0.0001
AAGAGGCAAGA S15A X77953 35 48 ↑  1.4 0.04
TGGCCCAAATT S16 X17665 155 48 ↓  3.2 < 0.0001
GGCCGCGTTCG S17 K02933 18 39 ↑  2.1 0.003
CAGAACCCACG S18 X57529 101 26 ↓  3.9 < 0.0001BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/3
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approximately 0.2–0.35% of total cell transcripts. The
high relative abundance of these ribosomal transcripts in
NGF-untreated cells can be appreciated by the observation
that of the 4 tags encountered more than 200 times in our
analysis, 2 (S15 and S24) encoded ribosomal proteins;
moreover, RP transcripts represented 6 of the 13 tags en-
countered from 100–200 times and 23 of the 36 tags en-
countered from 50–100 times.
The data in Table 1 and Figure 1 show that NGF treatment
resulted in an overall decrease in relative abundance of
transcripts encoding RPs (from 5.2% to 3.5% of total).
This may reflect in part our observation that NGF treat-
ment increases the numbers of transcripts representing
low-abundance genes [11]. Nevertheless, transcripts for ri-
bosomal proteins remained among the most highly ex-
pressed in the NGF-treated cells. For instance, tags for RPs
L13A, L31, L37A, S24 and S29 had relative abundances of
0.1% or more. Of the 56 most abundantly expressed tags
in NGF-treated cells, 21 represent ribosomal transcripts.
NGF selectively regulates the expression of transcripts en-
coding ribosomal proteins
In addition to yielding an overall decrease in the abun-
dance of RP transcripts relative to total cellular transcripts,
long-term NGF treatment also promoted selective changes
in relative expression of transcripts encoding individual
RPs (Table 1, Figs. 2,3). Monte-Carlo simulation analysis
of the SAGE data indicated that nearly half (a total of 35)
of the 74 RP transcripts underwent changes that were sig-
nificant at the P ≤  0.01 level (see Table 1). Of these 35
transcripts, 2/3 were down-regulated in response to NGF.
Figure 2 shows the distribution of fold-changes in tran-
script levels in response to NGF. 47 of the 74 RP tran-
scripts were either invariant or showed changes of 2-fold
or less; 10 individual transcripts decreased by 3–5 fold
(L12, L18, L24, L28, L30, S15, S16, S18, S19 and S24) and
one was elevated by more than 3-fold (L17).
In a past study [11], the differences in NGF-promoted
gene expression revealed by SAGE analysis of our libraries
were found to be highly reliable based on 1) the absence
of regulation shown by a number of anticipated "house-
keeping" genes including β -actin, 2) the observation that
the vast majority of transcripts were not responsive to
NGF, 3) the detection of anticipated changes in expres-
sion of a number transcripts previously reported to be
NGF responsive, and 4) the agreement in relative expres-
sion of 20 genes as revealed by SAGE and northern blot
analyses. To further confirm the reliability of our SAGE
findings, we used real time quantitative PCR to compare
levels of 5 different RP transcripts in PC12 cells treated
with or without NGF for 9–12 days. As shown in Figure 4,
both techniques revealed similar changes in expression.
Rapid regulation of an RP transcript by NGF
We next determined the time course with which NGF reg-
ulates an RP transcript. For this purpose, we studied RP L9
which undergoes a 2.7-fold elevation in response to long-
term NGF treatment. Because the changes in expression
are relatively small, we used real time PCR for this end. As
shown in Figure 5A, the relative abundance of transcripts
encoding RP L9 were significantly upregulated by 1 hr of
NGF treatment (1.8 ± 0.2-fold, n = 14) whereas there was
ACCAAGATCTA S19 X51707 136 28 ↓  4.8 < 0.0001
CCTACCAAGAC S20 X51537 8 16 ↑  2.0 0.07
GGTCTGGCTAG S21 X79059 0 3 ↑  3.0 na
CCGTGGGTGAT S23 X77398 52 68 ↑  1.3 0.03
GCCTTTATGAG S24 X52445 310 87 ↓  3.6 < 0.0001
CCGCCCAAAGA S25 X62482 90 43 ↓  2.1 0.0003
GAAAAATAAAA S26 X02414 35 16 ↓  2.2 0.03
CACAAACGGTA S27-1 AF184893 99 46 ↓  2.2 0.0004
GGTAGCCACTT S27A X81839 33 77 ↑  2.3 < 0.0001
GAATGACCTGC S28 X59277 40 37 ↓  1.1 0.4
CTAGTCTTTGT S29 X59051 125 123 ↓  1.0 0.3
GTTCTCTGGCT S30 X62671 29 33 ↑  1.2 0.3
GGATTCGGTCT P0 Z29530 40 55 ↑  1.4 0.04
TCCAATAAAGA P1 R5RT12 96 48 ↓  2.0 0.0002
GGATTTGGCCT P2 X15098 83 84 ↑  1.0 0.3
GGAGGTTATGC 40 KD 
RP
D25224 83 34 ↓  2.4 < 0.0001
Rat SAGE tags and the corresponding ribosomal proteins (and GenBank accession numbers) are given along with the number of times each tag was 
detected. For cells before and after NGF treatment, a total of 76,280 and 87,004 11 bp tags were analyzed, respectively. Tag numbers for non-
treated cultures were normalized against those for NGF treated cultures. P values were calculated by Monte Carlo simulations using SAGE soft-
ware. Fold changes in which P ≤  0.01 are expressed in bold.
Table 1: The effect of NGF (9 days treatment) on expression levels of transcripts for various ribosomal proteins in PC12 cell cultures BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/3
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no significant change in transcripts encoding RP S29,
which does not undergo long-term NGF regulation. A
time course (Figure 5B) revealed that elevation of L9 tran-
scripts reaches maximal levels within 8 hrs of NGF expo-
sure.
Discussion
NGF regulates expression of RP transcripts
In the present work, we used SAGE profiling to identify
and quantify the relative numbers of transcripts for 74 ri-
bosomal proteins in rat PC12 cells before and after long-
term exposure to NGF. This has permitted us to detect se-
lective changes in transcripts encoding specific RPs.
A number of criteria support the reliability of our findings.
The first regards the assignment of SAGE tags to specific
RP transcripts. We required that all matching ESTs or tran-
scripts have clearly definable poly A tails and poly ade-
nylation signals. Due to the extensive data base for rat RP
transcripts, it was possible to make all matches with rat se-
quences. In addition, we used 15 mer (CATG +11) base
SAGE tags for our analysis; we have reported [11] that this
leads to a significantly more reliable matching of SAGE
tags to genes than with the often-used 14-mer tags. A sec-
ond indicator of reliability stems from prior analysis of
our SAGE libraries and data obtained from them [11]. For
instance, we have shown that our SAGE libraries show lit-
tle or no NGF-promoted changes in tag numbers for tran-
scripts encoding a number of housekeeping proteins.
Moreover, a number of transcripts previously found by al-
ternative technologies to respond to NGF treatment,
showed similar changes in our SAGE profiling study. Fi-
nally, Northern blot analysis verified SAGE-predicted re-
sponses of over 20 transcripts to NGF treatment. A third
criterion for reliability was that Monte Carlo simulation
indicated that many of the NGF-promoted responses of
RP transcripts were at a probability of P < 0.01. Because of
the relatively high abundance of many RP transcripts,
even comparably small changes in expression could be de-
tected at this level of significance. A last criterion was that
we used real time RT-PCR to verify effects of NGF on five
RP transcripts.
A previous study by Lee et al. [8], based on comparison of
a total of approximately 7,000 random ESTs from naïve
and NGF-treated PC12 cells, reported an NGF-promoted
increase in expression of RPL7 transcripts and a decrease
in RPL19 transcripts. This contrasts with the current data
which revealed no significant change in expression of ei-
ther of these transcripts. The reason for this discrepancy is
unclear, but could in part originate from the relatively
small number of transcripts that were surveyed in the
former study. To our knowledge, there are currently no
other reports regarding effects of NGF on levels of ribos-
omal transcripts.
Relative levels of RP transcripts
Our observations indicate that there is a wide range in the
numbers transcripts per cell that encode individual RPs.
For instance, both before and after NGF treatment, there
was over a 10-fold difference in the relative numbers of
Figure 1
Relative abundances of RP transcripts before and after long-
term NGF treatment. A. Transcripts for RP L3–L41 and P0–
P2. B. Transcripts for RP S2–S30 and 40 KD RP. Relative
abundances were calculated on the basis of total numbers of
tags evaluated and numbers of tags corresponding to each RP
transcript.
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transcripts for RPs L7, L22, S21 as compared to those en-
coding RP S29. Because of the general scarcity of antisera
prepared against mammalian RPs, we do not know
whether this is reflected at the protein level. However, for
a number of other NGF-regulated transcripts in PC12
cells, there is a good correlation between relative levels of
message and protein [11,16,17]. Thus, it may be that al-
though levels of individual RPs are assumed to be similar
to one another, some may be present in limiting numbers.
Alternatively, there may be a considerable disparity be-
tween relative abundances of RP transcripts and their cor-
responding proteins
A recent SAGE study of targets for N-myc in a human neu-
roblastoma cell line [18], reported relative abundances for
66 RP transcripts. The existence of such data permit us to
compare the relative levels of RP transcripts in two cell
types (neuroblastoma and pheochromocytoma) of relat-
ed origin (i.e., neural-crest-derived) that both have the po-
tential for neuronal differentiation. The 74 RP transcripts
detected here represented 5.2% of the total transcripts in
NGF-untreated PC12 cells and 3.5% after NGF treatment.
By contrast, the 66 RPs reported in the neuroblastoma
study accounted for 4.1% of total transcripts for cells with-
out N-myc over-expression and 12.6% for such cells trans-
fected with N-myc. Thus, for non-N-myc transfected
neuroblastoma cells and PC12 cells (± NGF) the contribu-
tion of total RP transcripts lies in a similar range and this
parameter is greatly elevated in neuroblastoma cells by N-
myc over-expression. With respect to transcripts for indi-
vidual RP's, there are many similarities as well as several
striking differences between the two cell types. When
NGF-untreated PC12 cells are compared with non-trans-
fected neuroblastoma cells, of the 55 RP transcripts detect-
ed in common for both systems, about half (a total of 28)
have relative abundances within a factor of 2. Twenty tran-
scripts are more than 3-fold higher in relative abundance
in PC12 cells. In two of these cases (S9 and S17) no tags
were detected in the non-transformed neuroblastoma
cells; in several other cases (S12, S24, L24) the relative
abundance in PC12 cells was over 20-fold that in the neu-
roblastoma cells. For most of these, expression of N-myc
elevated the neuroblastoma levels to relative abundances
within 2-fold of those in PC12 cells. However, for L24 and
S24, the relative abundance in N-myc-expressing neurob-
lastoma cells was still 1/3 that in PC12 cells. Finally 7 RP
transcripts (L7, L11, L21, L30, S7, S8 and P2) were of 3–5
times lower abundance in PC12 cells than in neuroblast-
oma cells and this difference was appreciably enhanced
when the NB cells were transfected with N-myc.
Figure 3
Incremental changes in expression of RP transcripts evoked by long-term treatment with NGF. NGF-promoted
changes in expression of RP transcripts are given in incremental units. Up-regulated transcripts are given as [(number of nor-
malized tag numbers + NGF/number of normalized tag numbers - NGF) - 1] and are thus expressed as positive values. Tran-
scripts that are down-regulated by NGF are given as –[(number of normalized tag numbers - NGF/number of normalized tag
numbers + NGF) - 1] and are thus expressed as negative values. For transcripts that do not change expression in response to
NGF, the incremental change is zero. A. Transcripts for RP L3–L41 and P0–P2. B. Transcripts for RP S2–S30 and 40 KD RP.
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We have also compared our RP results with those for
SAGE carried out with pooled human adult brain (tissue
supplied by Gregory J. Riggins:  [http://www.nc-
bi.nlm.nih.gov/sage/sagerec.cgi?rec=161] ). Comparison
with data for NGF-treated cells reveals similarity in rela-
tive abundance within a factor of 2 for 39 of the 57 RP
transcripts in common between the libraries and 48 of 57
to within a factor of 3. However, several large differences
do occur. For example the relative abundances of tran-
scripts encoding RPs L9, L39, S24, S13, and S17 are 5–10-
fold higher in NGF-treated PC12 cells than in the pooled
brain library and transcripts for RP L28 are 8-fold lower.
These observations reinforce the notion that expression of
individual RP transcripts can be significantly variable
from cell type to cell type as well as sensitive to extrinsic
signals.
Potential significance of RP transcript regulation
Although the ribosome has been considered as a "molec-
ular machine" [19], it is of interest that the transcripts en-
coding individual proteins of this organelle are subject to
regulation by NGF. Two related questions emerge regard-
ing these findings: how do these changes compare with
previous reports for regulation of RP transcripts and what
might be the functional consequences of these changes?
A number of studies have employed a variety of tech-
niques to detect changes in gene expression associated
with the oncogenic state and have reported selective eleva-
tion of specific RP transcripts in tumors. Examples include
RPs L7a, L37 and S14 in prostate tumors and cell lines
[20]; RPs L5, L7A, L18, S3, S6, S8, S12, S13, S28, P0 and
P1 in colorectal cancers and cell lines [21–26]; L5 in astro-
cytomas [27]; L18a in squamous cell carcinoma [28]; L19
in breast tumors that over-express erbB-2 [29]; RPs S3A,
S4, and S17 in lymphoid malignancies [30]; L38, S4, P0,
and P1 in rhabdomyosarcoma cell lines [31]; and P0, P1,
P2, L5, L9, L35, L39, S3A, S10, and S17 in liver tumors
[32]. In addition, as noted above, a recent SAGE study
identified targets of N-myc in a human neuroblastoma
cell line [18]. Of 114 up-regulated genes detected, 66 en-
coded RPs with elevations ranging from 40% to 37-fold.
Several of these genes were also up-regulated by c-myc.
Taken together, these findings indicate that the transition
to the transformed state is associated with elevation of
various RP transcripts. A potential interpretation of such
observations is that this up-regulation reflects the en-
hanced rate of cell division in tumor cells and the require-
ment for greater levels of protein synthesis. In agreement
with this possibility, transcripts encoding RPs L6 and S7
are reported to be up-regulated in regenerating liver [33].
However, for the study involving responses of neuroblas-
toma cells to N-Myc, despite the massive up-regulation of
RP transcripts, there was no over-all increase in the rate of
protein synthesis [18].
Before considering potential functional consequences of
the changes in RP expression described here as well as
elsewhere, it must be conceded that changes in transcript
abundance may not necessarily lead to changes in protein
expression. The present lack of available antibodies/an-
tiserum to most mammalian RPs hampers such a determi-
nation. However, even if cases occur in which altered RP
transcript expression does not lead to changes in expres-
sion of the corresponding protein, our and others' find-
ings regarding selective regulation of RP transcripts would
then raise the interesting issue as to why, and the mecha-
nism by which, transcript and protein expression are un-
coupled.
If at least some of the NGF-promoted alterations in RP
transcript abundance lead to changes in expression of the
corresponding proteins, what might be the functional
consequences? In the present system, NGF converts prolif-
erating PC12 cells to a non-proliferating neuronally differ-
entiated state. Our findings reveal that the relative overall
abundance of transcripts for RP proteins fell by 1/3 in re-
sponse to NGF. In addition, nearly half of the individual
RP transcripts detected showed significant changes in ex-
pression and approximately 2/3 of these were decreases.
This overall decrease in NGF-promoted RP transcript ex-
pression and the preponderance of decreases in expres-
sion of specific RP transcripts compared to increases
would favor the interpretation that the changes observed
here reflect, at least in part, the transition to the non-di-
viding phenotype. On the other hand, we observed that
Figure 4
Comparison of effects of long-term treatment with NGF on
expression of RP transcripts as determined by SAGE and
real-time PCR. Changes in expression are expressed as fold
up- or down-regulation by NGF. Up-regulated transcripts are
given as the ratio of normalized tag numbers +NGF/-NGF
and are expressed as positive values. Transcripts that are
down-regulated by NGF are given as the ratio of normalized
tag numbers -NGF/+NGF and are expressed as negative val-
ues. Values for real-time PCR are given as means ± SE (n = 4-
6) and were normalized against the levels of beta actin mes-
sage.
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many of the RP transcripts did not show significant re-
sponses to NGF and that a number showed increases in
expression. This suggests that the situation is likely to be
more complex with individual RPs perhaps playing specif-
ic roles not simply associated with the state of cell prolif-
erative capacity. In agreement with this, we found no
significant change in expression of RP S29 transcripts even
though these have been reported to be present at low lev-
els in growth phase cells and elevated in quiescent cells
[34].
In addition to leaving the cell cycle, NGF-treated PC12
cells undergo neuronal differentiation. This raises the pos-
sibility that some of the observed changes, as for many
other NGF regulated genes, is related to acquisition of the
neuronal phenotype. An analysis of gene regulation in hu-
man NTERA2 cells induced to leave the cell cycle and neu-
ronally differentiate in response to retinoic acid revealed
decreases in RP transcripts including L3, L7, L8, L10, L13,
L39, S2, S6, S13, S16, S20, S19, S23, S27A and P0 [35]. Of
these, In the present study only RP transcripts L8 and S6,
S16, S19 showed significant down regulation in response
to NGF whereas the others found in the NTERA2 study ei-
ther did not show changes that were significant at the P ≤
.01 level or underwent a significant increase (RP S27A).
Curcic et al. [36] reported that differentiation of BC3H1
myocytes is accompanied by a drop in L32 gene transcrip-
tion; in contrast, we found no significant change in tran-
scripts encoding this RP. In another study, RPs L35a and
S5 were down regulated during murine erythryolukemia
cell differentiation [37]; we also observed decreases in
these transcripts. Mutation of RP S19 is associated with
Blackfan's anemia and therefore appears to play a selective
role in differentiation/proliferation of erythropoetic cells
[39]. Here, NGF resulted in a nearly 5-fold drop in S19
transcripts. Thus, although changes in expression of spe-
cific RP genes may be associated with differentiation, the
pattern of such changes may reflect the particular cell type
and differentiation stimulus that is involved.
Another condition associated with changes in RP expres-
sion is apoptotic death. RP L4/L1 transcripts, which were
not significantly affected by NGF, are selectively upregu-
lated in PC12 cells prior to 5 aza cytosine-induced death
and over-expression of this gene in COS-7 cells induces
apoptosis [39]. Over-expression of L7, L13A, S29 have
been also reported to induce apoptosis [40,41]. In the
present study, NGF promoted little if any change in ex-
pression of these RP transcripts. Thus, although NGF is an
effective anti-apoptotic factor, these actions do not appear
to be mediated by down-regulation of potentially death-
inducing RPs.
At present, in contrast to studies on bacterial and archael
ribosomes, relatively little is known about the functions
of individual mammalian ribosomal proteins ([42]. How-
ever, assuming that changes in message abundance lead to
alterations in protein levels, it is reasonable to anticipate
that the NGF-promoted effects observed here may affect
the protein synthetic capacity of the cell in some manner.
Such changes are unlikely to be global; NGF does affect
the cellular rate of protein synthesis, but this seems to be
due at least in part to post-translational modification of
the translational machinery [43]. The alternative is that
the changes reported here may result in selective effects on
translation of specific messages.
A final, and important possibility to consider is that a
number of RPs appear to possess extraribosomal func-
tions [44] and consequently that the changes reported
here may lead to responses that do not directly relate to ri-
bosomal function. For example, RP L18, which was signif-
icantly down-regulated by NGF, has been reported to
negatively regulate double-stranded RNA (dsRNA)-acti-
vated protein kinase (PKR) [45]. As an additional example
RP S19, which is also down-regulated by NGF, has been
implicated in erythropoiesis and has also been described
as a monocyte chemotactic factor [46]. As one last exam-
ple, rat RP L9 which we found to be up-regulated by NGF
starting within a few hours and maximally by 8 hrs, has
been shown to be the ortholog of the yeast gene grc5
Figure 5
Rapid regulation of RP L9 transcripts by NGF. A. Elevation of
RP L9 transcripts after 1 hr of NGF exposure. PC12 cell cul-
tures were treated with or without NGF for 1 hr and used
for preparation of RNA and cDNA. Relative levels of L9 and
S29 transcripts were determined by real-time PCR with nor-
malization against levels of transcripts for GAPDH. Data are
given as ratios for values of [NGF treated/untreated] and are
expressed as means ± SE (n = 14 for L9 and n = 6 for S29).
B. Time course for NGF response of transcripts encoding
RP L9. PC12 cultures were treated with NGF for the indi-
cated times and used for preparation of RNA and cDNA.
Relative levels of L9 transcripts were determined by real-
time PCR with normalization against levels of transcripts for
GAPDH. Values are given as means ± SE (n = 3).
0
1
2
RP S29      RP L9
R
A
T
I
O
 
O
F
 
T
R
A
N
S
C
R
I
P
T
 
N
U
M
B
E
R
[
0
 
N
G
F
/
1
 
H
R
 
N
G
F
]
0
2
4
02468
HRS OF NGF TREATMENT
R
E
L
A
T
I
V
E
 
A
B
U
N
D
A
N
C
E
 
O
F
 
R
P
 
L
9
 
T
R
A
N
S
C
R
I
P
T
S
A BBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/3
Page 9 of 11
(page number not for citation purposes)
which appears to be involved in multiple cellular func-
tions including growth control, cytoskeleton control and
energy metabolism [47]. Identification of NGF-regulated
RPs should now facilitate exploration of their potential
roles in the responses of cells to neurotrophins.
Conclusions
1. SAGE analysis provides a reliable, quantitative picture
of ribosomal protein expression in PC12 cells before and
after long term exposure to NGF.
2. Transcripts for ribosomal proteins are among the most
abundant transcripts in the cells; however there is a wide
range between numbers of transcripts for individual RP
transcripts.
3. NGF promotes an overall decrease in relative RP tran-
script expression (for the 74 RP transcripts detected, from
approximately 5% of total transcripts to 3.5%). This drop
represents a decrease in relative expression of individual
RP transcripts as well as an increase in message complexity
in NGF-treated cells.
4. Long term NGF treatment of PC12 cells promotes sta-
tistically significant changes in expression of over half of
the transcripts encoding ribosomal proteins. Decreases in
expression outnumbered increases by a ratio of approxi-
mately 2:1. The largest observed changes in expression are
in the range of 3–5 fold.
5. For at least one RP transcript (RPL9) the response to
NGF is rapid; an elevation is detected within 1 hr of NGF
exposure and reaches maximum regulation by 8 hrs.
6. Examination of the literature reveals many other re-
ports in which expression of individual or groups of RP
transcripts are regulated in response to growth factors, dif-
ferentiation agents or malignant transformation. Compar-
ison with the present data indicate that changes in
ribosomal protein transcripts is regulated in a cell and
state dependent fashion with a large diversity in the par-
ticular RP transcripts that are subject to regulation. Thus,
although the ribosome may be regarded as a "machine"
there is a good deal of potential for plasticity with respect
to the expression of its various components. This raises
the possibilities that growth factors and other cell regula-
tors may affect ribosomal function, and thereby the capac-
ity of cells to transcribe specific transcripts.
7. In the absence of information about the specific func-
tions of most individual RPs in mammalian cells, one can
only speculate at present on the physiologic significance
of the reported changes. However, it seems highly plausi-
ble that the observed responses may play roles in NGF-
promoted neuronal differentiation. This may be mediated
in part by selective effects on translation of certain mes-
sages. In addition, past findings support the possibility
that at least some of the regulated RPs have extra-ribosom-
al actions that may affect neuronal differentiation and
function.
Materials and Methods
SAGE and matching SAGE tags with RP transcripts
SAGE libraries were prepared from naïve and 9-day NGF-
treated PC12 cells and sequenced as previously described
[11]. To match SAGE tags with RP transcripts, tags were in-
itially analyzed with the National Center for Biotechnolo-
gy Information (NCBI) rat SAGE tag to gene mapping
database  [ftp://ncbi.nlm.nih.gov/pub/sage/map/Rn/
Nla3] , which matches possible 14-mer tags with known
rat genes and expressed sequence tags (ESTs). With the use
of sequences present in the NCBI UNIGENE rat database
[http://www.ncbi.nlm.nih.gov/UniGene/Rn.Home.html]
 potential matches were further scrutinized to determine
whether there was a match at the 15th base and to deter-
mine whether the matched sequence was at the most 3'
end of a known rat transcript or EST. We considered only
cases in which a clear poly(A) tail and a polyadenylation
signal were present at the 3' end of the transcript or EST.
Appropriate ESTs were further analyzed by an advanced
BLAST search for matches with known rat RP genes. Mon-
te-Carlo simulation analysis of the SAGE data was carried
out using the SAGE 300 software package [13].
Real time quantitative PCR analysis
PC12 cells were cultured as previously described [12] in
complete medium (85% RPMI 1640 medium, 10% horse
serum, 5% fetal bovine serum). Replicate cultures were
treated with 50 ng/ml rhNGF (kindly donated by Genen-
tech, Inc.) for the indicated times. Total cellular RNA was
isolated as described previously [11] and 1.2 – 5 µg was
used for reverse transcription with 5'-T30NN-3' primer us-
ing Superscript II Rnase H-RT according to the manufac-
turer's specifications (Life Technologies, Grand Island,
NY). Quantitative real time PCR reactions were performed
as described by Troy et al. [48]. GAPDH was used to nor-
malize input cDNA for samples originating from short-
term NGF treatments and β -actin was used for this pur-
pose for samples with long-term NGF exposure.
Forward and reverse primers pairs used for quantitative
PCR were: S29, 5'GGTATCACAGGGTAGACAGT3' and
5'GGTATCACAGGGTAGACAGT3'; L9, 5'GAACTCTGAG-
GAGGGACTTC3' and 5'AAACTGTACTTGTTATCAGGA-
T3';  S27-1, 5'CGGCACGAGCGACCTCCCTA3' and
5'GTTCCCACTCATCTTGAATC3';  L24, 5'CAAGAAAGG-
ACAGTCGGAAA3' and 5'TTCACAGGCTTCACAATCTT3';
S19, 5'TAACCAGCAGGAGTTCGTCA3' and 5'TTTGTTCT-
AATGCTTCTTGTT3'; β -Actin, 5'ATCCTGACCCTGAAGTA-
CCC3' and 5'TACGACCAGAGGCATACAG3'; andBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/3
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GAPDH, 5'GAAACCTGCCAAGTATGATGA3' and 5'TCTC-
TCTTGCTCTCAGTATCC3', respectively.
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